Dr. Khalid Khan is an accomplished chemist with extensive expertise in organic chemistry and medicinal research. He obtained his PhD from Huazhong University of Science and Technology in China, focusing on the design and synthesis of novel dendro-calix[4]arenes. Currently, he serves as an Associate Professor at Islamia College University in Peshawar, Pakistan, where he leads various research projects and supervises graduate and undergraduate students. His work has significantly contributed to the field of drug discovery, particularly in computational and medicinal chemistry.
Author Metrics
Scopus Profile
Dr. Khan has published over 25 research articles in reputable journals, showcasing his research impact and contribution to the field of chemistry. His work has garnered numerous citations, reflecting the relevance and influence of his research on both national and international platforms. His publication metrics highlight his active engagement in advancing scientific knowledge, particularly in the areas of antiviral drug development and nanotechnology.
- Citations: 414 citations across 379 documents
- Documents: 21 published works
- h-index: 9
Education
Dr. Khan completed his PhD in Chemistry from Huazhong University of Science and Technology, China (2008-2013), where he conducted groundbreaking research on nonionic amphiphilic dendro-calix[4]arenes. He holds a Master’s degree in Chemistry from the University of Peshawar (2002-2004), where he graduated with first-class honors, and a Bachelor’s degree in Biological Science from Government College Peshawar (2000-2002).
Research Focus
Dr. Khan’s research primarily revolves around organic chemistry, with a special focus on the synthesis and characterization of bioactive compounds. He is particularly interested in the development of antiviral agents and the computational modeling of drug interactions with viral proteins. His innovative research projects often explore the structure-activity relationships of compounds to enhance therapeutic efficacy.
Professional Journey
Beginning his career as a lecturer in 2005, Dr. Khan progressively advanced to the role of Associate Professor in 2020 at Islamia College University. Throughout his tenure, he has significantly contributed to the academic environment by designing curricula, supervising research, and engaging in community service. His professional journey is marked by a commitment to education, research, and the development of future scientists.
Honors & Awards
Dr. Khan has received several prestigious awards, including the Pakistan and Chinese Government Cultural Exchange Scholarship for his doctoral studies. He was recognized as the topper in his Master’s program, reflecting his dedication and excellence in the field of chemistry. His achievements have earned him a respected place among his peers in academia.
Publications Noted & Contributions
Among his numerous publications, key works include research on the design and synthesis of novel dendro-calix[4]arenes, antiviral drug development, and the characterization of compounds with potential therapeutic applications. His contributions have advanced understanding in various areas of organic chemistry and nanotechnology, facilitating further research in these domains.
Homology modeling and molecular docking study of metabotropic glutamate receptor 5 variant F: An attempt to develop drugs for treating CNS diseases
- Authors: Ahmad, N., Khan, K., Rashid, H.U., Ullah, R., Ali, E.A.
- Journal: Zeitschrift für Physikalische Chemie
- Year: 2024
- Volume: 238, Issue 8, Pages 1551–1577
- Citations: 1
Direct synthesis, characterization, in vitro and in silico studies of simple chalcones as potential antimicrobial and antileishmanial agents
- Authors: Ur Rashid, H., Khan, S., Irum, Shah, T., Khan, K.
- Journal: Royal Society Open Science
- Year: 2024
- Volume: 11, Article 240410
- Citations: 0
Homology modeling and molecular docking study of corticotrophin-releasing hormone: An approach to treat stress-related diseases
- Authors: Ahmad, N., Khan, K., Khan, S.W., Ullah, R., Ali, E.A.
- Journal: Open Chemistry
- Year: 2024
- Volume: 22, Article 20240069
- Citations: 0
Biological investigations of Aspergillus ficuum via in vivo, in vitro and in silico analyses
- Authors: Shah, Z.A., Khan, K., Shah, T., Muhammad, A., Rashid, H.
- Journal: Scientific Reports
- Year: 2023
- Volume: 13, Article 17260
- Citations: 1
Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques
- Authors: Shah, Z.A., Khan, K., Rashid, H.U., Jaremko, M., Iqbal, Z.
- Journal: BMC Microbiology
- Year: 2022
- Volume: 22, Article 295
- Citations: 4
Research Timeline
Dr. Khan’s research trajectory spans over a decade, beginning with his PhD studies from 2008 to 2013, followed by various research projects involving computational analyses and synthesis of organic compounds. His ongoing projects encompass a wide range of studies aimed at understanding and inhibiting viral proteins, particularly related to SARS-CoV-2 and other pathogenic viruses.
Collaborations and Projects
Dr. Khan has collaborated with both national and international researchers on diverse projects, enhancing the scope and impact of his research. These collaborations have resulted in joint publications and a collective effort to address significant challenges in medicinal chemistry and virology. His ability to work across disciplines and institutions underscores his commitment to collaborative scientific inquiry.
Conclusion
Dr. Khalid Khan’s recognition as a Best Researcher reflects his significant contributions to organic chemistry and medicinal research. His publication record and collaborative efforts enhance his impact within the scientific community. By addressing areas for improvement, such as increasing citation metrics and expanding research diversification, Dr. Khan can further strengthen his position as a leader in his field. His commitment to education and research not only benefits his students but also contributes to the broader scientific landscape, making his work essential for advancements in drug discovery and public health.